USEC Inc (NYSE:USU) unable to conclude uranium enrichment deal, Rexahn Pharmaceuticals, Inc (NYSEMKT:RNN)

Posted by Nathan Alexander May 28, 2013 0 Comment 1601 views


Hartford, CT 05/28/2013 (GDPInsider) – In Friday’s trading session, USEC Inc (NYSE:USU) dipped by 7.18%. Its opening price of $0.41 rose to touch an intraday high of $0.42 which eventually headed down to close at $0.36 per share. More than 1.46 million shares exchanged hands in the last trading session. This number stood above the average volume of 0.774 million that was measured over a 30-day period.

On Friday, USEC Inc (NYSE:USU) announced that it had been unable to conclude a short-term extension for uranium enrichment deal at its Paducah Gaseous Diffusion Plant located in Kentucky. The company will commence stopping uranium enrichment towards May end. This Paducah plant is the only uranium enrichment facility in the U.S that is owned as well as operated by the United States. The plant is leased from the U.S. Department of Energy by USEC Inc (NYSE:USU). USEC is an international energy company and a supplier of low-enriched uranium that is used in commercial nuclear power plants.

Is USU a solid investment at these levels? Get valuable updates and exclusive insights here.

In Friday’s trading session, Rexahn Pharmaceuticals, Inc (NYSEMKT:RNN) dipped by 6.95%. Its opening price of $0.39 rose to touch an intraday high of $0.40 which eventually headed down to close at $0.35 per share. More than 1.12 million shares exchanged hands in the last trading session. This number stood above the average volume of 0.670 million that was measured over a 30-day period.

The 200-days moving average of the stock is $0.378 and is above the $0.320, 50-days moving average. This is distinct sign of pessimism on the Rexahn Pharmaceuticals, Inc (NYSEMKT:RNN) stock. The share price is now 54.17% which is below its previous 52-week high of $0.81 and 32.57% above the previous 52-week low of $0.28. Over a period of 5 days, the stock has given a 21.87% return. The performance of the RNN stock has been positive over one month and was 21.87%.

How Should Investors Trade RNN Now? Get key and important information right here.

Disclosure:

WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.


About Nathan Alexander

Nathan Alexander holds bachelor’s degrees in Journalism and European Studies from Boston University. Nathan reports round up the day’s business and financial market news and include keynote interviews with major business players and updates on Asian, European and US stock markets. He has interviewed heads of leading European banking institutions such as European Central Bank President Jean-Claude Trichet and HSBC Chairman Stephen Green, and CEOs from the business world including Microsoft founder Bill Gates, Virgin Chairman Sir Richard Branson and former Porsche President and CEO Dr Wendelin Wiedeking.

View all post by Nathan Alexander Visit author's website

Write Your Comment